Adebiyi A, McNally EM, Jaggar JH. Vasodilation induced by oxygen/ glucose deprivation is attenuated in cerebral arteries of SUR2 null mice. Am J Physiol Heart Circ Physiol 301: H1360-H1368, 2011. First published July 22, 2011 doi:10.1152/ajpheart.00406.2011.-Physiological functions of arterial smooth muscle cell ATP-sensitive K ϩ (KATP) channels, which are composed of inwardly rectifying K ϩ channel 6.1 and sulfonylurea receptor (SUR)-2 subunits, during metabolic inhibition are unresolved. In the present study, we used a genetic model to investigate the physiological functions of SUR2-containing KATP channels in mediating vasodilation to hypoxia, oxygen and glucose deprivation (OGD) or metabolic inhibition, and functional recovery following these insults. Data indicate that SUR2B is the only SUR isoform expressed in murine cerebral artery smooth muscle cells. Pressurized SUR2 wild-type (SUR2wt) and SUR2 null (SUR2nl) mouse cerebral arteries developed similar levels of myogenic tone and dilated similarly to hypoxia (Ͻ10 mmHg PO2). In contrast, vasodilation induced by pinacidil, a KATP channel opener, was ϳ71% smaller in SUR2nl arteries. Human cerebral arteries also expressed SUR2B, developed myogenic tone, and dilated in response to hypoxia and pinacidil. OGD, oligomycin B (a mitochondrial ATP synthase blocker), and CCCP (a mitochondrial uncoupler) all induced vasodilations that were ϳ39 -61% smaller in SUR2nl than in SUR2wt arteries. The restoration of oxygen and glucose following OGD or removal of oligomycin B and CCCP resulted in partial recovery of tone in both SUR2wt and SUR2nl cerebral arteries. However, SURnl arteries regained ϳ60 -82% more tone than did SUR2wt arteries. These data indicate that SUR2-containing KATP channels are functional molecular targets for OGD, but not hypoxic, vasodilation in cerebral arteries. In addition, OGD activation of SUR2-containing KATP channels may contribute to postischemic loss of myogenic tone. adenosine 5=-triphosphate-sensitive potassium channels; sulfonylurea receptors; hypoxia; ischemia; mitochondria AEROBIC METABOLISM is the primary source of ATP in the brain (46). A reduction in oxygen supply (hypoxia) provokes anaerobic metabolism, which is inadequate to meet cellular energy demand, resulting in brain injury (46). A reduction or cessation of brain blood supply (cerebral ischemia) leads to oxygen and glucose deprivation (OGD) and neurological injury seen in a variety of pathological conditions, including stroke, cerebral trauma, and subarachnoid hemorrhage (46). Reperfusion after a period of cerebral ischemia can also exacerbate cellular injury (42). Thus cerebral blood flow is tightly regulated to ensure that an appropriate amount of oxygen is delivered to the brain (46).
AEROBIC METABOLISM is the primary source of ATP in the brain (46) . A reduction in oxygen supply (hypoxia) provokes anaerobic metabolism, which is inadequate to meet cellular energy demand, resulting in brain injury (46) . A reduction or cessation of brain blood supply (cerebral ischemia) leads to oxygen and glucose deprivation (OGD) and neurological injury seen in a variety of pathological conditions, including stroke, cerebral trauma, and subarachnoid hemorrhage (46) . Reperfusion after a period of cerebral ischemia can also exacerbate cellular injury (42) . Thus cerebral blood flow is tightly regulated to ensure that an appropriate amount of oxygen is delivered to the brain (46) .
Cerebral blood flow is dependent on the contractile status of resistance-size arteries. An increase in intravascular pressure induces a membrane depolarization that activates myocyte voltage-dependent Ca 2ϩ channels, leading to an elevation in arterial wall intracellular Ca 2ϩ concentration that induces vasoconstriction (9) . This reaction, termed the "myogenic response," is important for systemic blood pressure regulation and circulatory blood flow autoregulation and provides resting arterial tone that can be altered by vasoconstrictors or vasodilators (9) . The response of blood vessels to changes in oxygen partial pressure depends on the anatomical origin of the vasculature (21) . Hypoxia dilates cerebral and systemic arteries and arterioles but constricts small distal pulmonary arteries and arterioles (23, 30) . Hypoxic vasodilation ensures adequate tissue perfusion during metabolic demand, whereas hypoxic pulmonary vasoconstriction redirects blood flow to oxygenrich areas of the lung (26) . Several mechanisms have been reported to mediate hypoxic vasodilation, including prostaglandin, adenosine, and nitric oxide generation (30) . The activation of large conductance Ca 2ϩ -activated K ϩ channels has also been proposed to mediate hypoxic vasodilation (3, 12, 30) . However, whether arterial myocyte ATP-sensitive K ϩ (K ATP ) channels mediate hypoxic vasodilation is unresolved, with both positive and negative results being reported (8, 18 -20, 22, 30, 33, 35, 39) . Thus the physiological functions of K ATP channels in mediating hypoxic vasodilation are poorly understood.
Vascular myocyte plasma membrane K ATP channels are comprised of inwardly rectifying K ϩ channel 6.1 (Kir6.1) and sulfonylurea receptor (SUR)-2B subunits (1, 27) . Mitochondrial K ATP (mitoK ATP ) channels have also been described, but their molecular composition and physiological functions in vascular myocytes are unclear (29) . Previous studies that investigated hypoxic regulation of arterial myocyte K ϩ channels have used responses to K ATP channel blockers as evidence for involvement. However, pharmacological modulators of K ATP channels can have nonspecific effects and can regulate both plasma membrane and mitoK ATP channels (34, 41, 43) . Furthermore, the effects of K ATP channel blockers may be modified by endogenous regulators of signal transduction, including cellular metabolism (40) . To investigate the physiological functions of K ATP channels in mediating hypoxia-and OGD-induced vasodilation, we studied cerebral arteries of both SUR2 nl mice, in which myocyte SUR2-containing K ATP channels are abolished, and humans (1, 4, 16, 37) .
Our data indicate that SUR2 contributes to vasodilation induced by OGD and inhibitors of mitochondrial ATP generation. In contrast, SUR2 is not required for hypoxic vasodilation. Our data also indicate that SUR2 contributes to the loss of cerebral artery autoregulation following restoration of oxygen and glucose. These data indicate that metabolic stress dilates cerebral arteries through the activation of myocyte SUR2-containing K ATP channels and that the activation of these channels during metabolic inhibition leads to detrimental vascular responses following reoxygenation.
MATERIALS AND METHODS
Animal protocols were reviewed and approved by the Animal Care and Use Committee at the University of Tennessee Health Science Center. Mice were housed and bred at the University of Tennessee Health Science Center Comparative Medicine Department animal core facility. SUR2 mutant mice used in the present study were originally generated by targeted disruption of nucleotide-binding domain 1 of SUR2, as previously described (5) . Mice were interbred, and the progeny was genotyped using genomic DNA isolated from tail clips of 3-wk-old littermates. A fresh human brain sample was obtained through National Disease Research Interchange (Philadelphia, PA) using an Institutional Review Board-exempt protocol.
Mouse cerebral artery tissue preparation and arterial smooth muscle cell isolation. Aged-matched, male and female mice (ϳ20 g) were euthanized with an overdose of pentobarbital sodium (150 mg/kg ip). The brain was removed and placed into oxygenated ice-cold (4°C) physiological saline solution of the following composition: (in mM) 112 NaCl, 4.8 KCl, 24 NaHCO 3, 1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 10 glucose, which was gassed with 21% O2-5% CO2-74% N2 to pH 7.4. Posterior cerebral, cerebellar, and middle cerebral arteries (Ͻ150 m diameter) were dissected from the brain and cleaned of adventitial connective tissue. Individual smooth muscle cells were enzymatically dissociated from cerebral arteries using a method similar to that previously described (15) . Briefly, cerebral arteries were placed into HEPES-buffered isolation solution, consisting of (in mM) 55 NaCl, 80 sodium glutamate, 5.6 KCl, 2 MgCl 2, 10 HEPES, and 10 glucose (pH 7.3 with NaOH), containing 0.5 mg/ml papain, 1 mg/ml dithioerythreitol, and 1 mg/ml bovine serum albumin for ϳ7 min (at 37°C), and immediately transferred to isolation solution containing collagenase F (1 mg/ml) and H (0.5 mg/ml), 100 M CaCl 2, and 1 mg/ml BSA for ϳ5 min (at 37°C). Arteries were subsequently washed in ice-cold isolation solution and triturated using a fire-polished glass pasteur pipette to yield single smooth muscle cells.
Reverse transcription-polymerase chain reaction. Spindle-shaped arterial smooth muscle cells were manually collected under an inverted Nikon TS 100 microscope by aspirating them into a borosilicate glass micropipette, yielding pure cell preparations as we have done previously (1) . Approximately 100 cells were used for each RT-PCR experiment. Total RNA was prepared from arterial smooth muscle cells using RNA MicroPrep kit (Zymo Research; Orange, CA) and whole heart and brain using TRIzol reagent (Invitrogen; Carlsbad, CA). cDNA was synthesized from RNA samples using iScript cDNA Synthesis kit (Bio-Rad; Hercules, CA). cDNA products were amplified by nested PCR using our previously designed gene-specific oligonucleotide primer pairs (1) . Specific primers for first-round and nested-PCR amplification of SUR1 were designed to generate cDNA fragments of 413 and 169 bp, respectively (1). To detect SUR2A and SUR2B transcripts, forward and reverse primers were designed within a region that is conserved in both splice variants (1) . This approach Fig. 1 . Murine cerebral artery myocytes express sulfonylurea receptor 2B (SUR2B). A: RT-PCR amplified transcripts for SUR1 (169 bp), SUR2A (320 bp), and SUR2B (144 bp) from murine heart cDNA, whereas only SUR1 and SUR2B were amplified from murine brain. In contrast, isolated, selected cerebral artery myocytes only express transcript for SUR2B. B: Western blots indicate that SUR2B is expressed in mouse brain and cerebral arteries and that SUR2B blocking peptide blocks SUR2B detection.
generates different size cDNA fragments for SUR2A (first-round PCR, 451 bp; and nested PCR, 320 bp) and SUR2B (first-round PCR, 275 bp; and nested PCR, 144 bp) (1) . PCR amplification was performed in an Eppendorf Mastercycler (Eppendorf; Westbury, NY) with the following reaction conditions: an initial denaturation at 95°C for 2 min, followed by 35 cycles (denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 45 s), with a final extension at 72°C for 10 min. Reaction conditions for first-round PCR and nested PCR were the same. PCR products were separated by agarose gel (2%) electrophoresis, followed by ethidium bromide staining and documentation on Kodak In Vivo F Pro Imaging System (Carestream Molecular Imaging, Rochester, NY).
Western blot analysis. Western blot analysis was performed on mouse brain and human brain and cerebral artery samples as previously described (47) . Briefly, mouse brain and human brain and cerebral artery samples were homogenized in 1ϫ Laemmli buffer containing 2% ␤-mercaptoethanol. Protein concentrations were determined spectrophotometrically. Proteins were separated by 7% gradient SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes using a Mini Trans Blot Cell (Bio-Rad). Blots were probed with a goat polyclonal anti-SUR2B or anti-SUR2B preabsorbed with a blocking peptide (Santa Cruz Biotechnology; Santa Cruz, CA), except for the cerebral artery sample in Fig. 1B that was probed with a rabbit polyclonal anti-SUR2B (BNJ-40, 1:500, a kind gift from Dr. Jonathan Makielski, University of Wisconsin, Ref 32) . Bands were visualized on a Kodak Image F-Pro system using a West Pico Chemiluminescence kit (Pierce; Rockford, IL).
Pressurized artery diameter measurements. A cerebral arteriole/ artery segment ϳ2 mm in length was cannulated at each end in a pressurized artery myograph chamber (Living Systems Instrumentation; Burlington, VT). The chamber was continuously perfused with physiological saline solution, equilibrated with a mixture of 21% O 2-5% CO2-74% N2, and maintained at 37°C. Intravascular pressure was altered using an attached reservoir and monitored using a pressure transducer. Vessel diameter was measured by using the automatic edge-detection function of IonWizard software (Ionoptix; Milton, MA) and digitized at 1 Hz using a personal computer. Intraluminal flow was absent during experiments.
Hypoxia was generated by purging bath solution with 95% N 2-5% CO2 in a gas-impermeant container for at least 40 min before use. Myograph chambers were then covered and continuously perfused with hypoxic solution for ϳ40 min using Tygon gas-impermeant tubing (Saint-Gobain Performance Plastics; Akron, OH). Dissolved PO 2 was monitored with an O2-sensitive electrode (Extech Instruments). Changing the perfusion solution from normoxia to hypoxia reduced the dissolved PO2 in the chamber from ϳ150 to Ͻ10 mmHg. An in vitro model of transient cerebral ischemia was also used by depriving arteries of oxygen (from ϳ150 to Ͻ10 mmHg) and glucose (from 10 to 0 mM) for ϳ40 min (11, 14, 36) . Recovery of arterial tone following reoxygenation and oxygen/glucose restoration was also measured after ϳ40 min. Tested compounds were applied via chamber perfusion. The magnitude of myogenic tone was calculated using the following equation: myogenic tone (%) ϭ (1 Ϫ active diameter/ passive diameter) ϫ 100.
Reagents. Unless otherwise specified, all chemicals were purchased from Sigma Chemical (St. Louis, MO).
Data analysis. Values are expressed as means Ϯ SE. Student's t-tests were used for paired or unpaired data, and analysis of variance followed by Student-Newman-Keuls post hoc test for multiple data sets. P Ͻ 0.05 was considered significant.
RESULTS

Murine cerebral artery myocytes express only SUR2B
subunits. To determine SUR isoform expression in murine cerebral artery myocytes, ϳ100 acutely isolated arterial myocytes were manually collected under a microscope using an enlarged patch-clamp pipette and used for RT-PCR, as we have previously done (1) . This procedure prevents message contamination from other vascular wall cell types (1). Only SUR2B transcript was amplified from cerebral artery myocyte cDNA (Fig. 1A) . In contrast, SUR1, SUR2A, and SUR2B were amplified from mouse whole heart cDNA and SUR1 and SUR2B from mouse brain cDNA (Fig. 1A) . Western blot analysis of mouse brain and cerebral artery lysates using an SUR2 antibody revealed a ϳ135-kDa band that was abolished by preabsorption of the antibody with a SUR2B blocking peptide (Fig. 1B) . These data indicate that murine cerebral artery myocytes express only SUR2B.
SUR2 is not required for hypoxic vasodilation but required for pinacidil-induced vasodilation in murine cerebral arteries.
The functional significance of SUR2-containing K ATP channels to hypoxic vasodilation in cerebral arteries was examined. Cerebral arteries (Ͻ150 m diameter) from SUR2 wild-type (SUR2 wt ) and SUR2 null (SUR2 nl ) mice were pressurized to 60 mmHg to induce a myogenic response, and responses to pinacidil, a K ATP channel activator, and hypoxia were studied. Fig. 2 . Myogenic tone is similar in cerebral arteries of SUR2 wild-type (SUR2wt) and SUR2 null (SUR2nl) mice. A: representative traces illustrating that an elevation in intravascular pressure from 10 to 60 mmHg induces a similar myogenic constriction in SUR2wt and SUR2nl cerebral arteries. B: mean myogenic tone in SUR2wt (n ϭ 37) and SUR2nl (n ϭ 38) arteries, pressurized to 60 mmHg. SUR2 wt and SUR2 nl arteries developed similar levels of myogenic tone (Fig. 2, A and B) . SUR2 wt and SUR2 nl arteries also developed myogenic tone at the same rate [time to halfmaximal myogenic tone (SUR2 wt , 46.4 Ϯ 6.7 min, n ϭ 37; and SUR2 nl , 48.0 Ϯ 6.8 min, n ϭ 38, P Ͼ 0.05)]. The mean passive diameter (determined by removal of extracellular Ca 2ϩ ) of SUR wt (186 Ϯ 4 m, n ϭ 37) and SUR2 nl (177 Ϯ 3 m, n ϭ 38) arteries were similar (P Ͼ 0.05). At 60 mmHg, pinacidil increased mean arterial diameter of SUR2 wt cerebral arteries by ϳ17 m, but by only ϳ5 m in SUR2 nl arteries (Fig. 3, A  and B) . In contrast, hypoxia (a reduction in PO 2 from 150 to Ͻ10 mmHg) induced a similar (ϳ17 m) and fully reversible vasodilation in SUR2 wt and SUR2 nl cerebral arteries (Fig. 3, C  and D) . The time to half-maximal hypoxia-induced dilation was also similar (P Ͼ 0.05) in SUR2 wt (2.8 Ϯ 0.4 min, n ϭ 7) and SUR2 nl (2.9 Ϯ 0.7 min, n ϭ 7) arteries. These findings indicate that SUR2-containing K ATP channels contribute to pinacidil-induced vasodilation but do not contribute to hypoxic vasodilation in cerebral arteries.
Human cerebral arteries express SUR2B and dilate in response to pinacidil and hypoxia. To determine the molecular and functional relevance of the mouse model to humans, we studied human cerebral arteries. The anonymous donor was a 53-yr-old Caucasian man with no history of vascular disease. Western blot analysis of human brain and cerebral artery lysates using an SUR2B antibody revealed a ϳ135-kDa band that was abolished by preabsorption of the antibody with a SUR2B blocking peptide (Fig. 4A) . Human cerebral arteries pressurized to 60 mmHg developed 17 Ϯ 3% (n ϭ 6 arteries) steady-state myogenic tone that was abolished by the removal of Ca 2ϩ from the bath solution (Fig. 4B) . The mean passive diameter of human cerebral arteries studied was 173 Ϯ 11 m (n ϭ 6 arteries). Pinacidil induced a mean vasodilation of ϳ12 m in myogenic human arteries, which reduced tone by ϳ43% (Fig. 4, C and D) . Hypoxia (PO 2 from 150 to Ͻ10 mmHg) increased mean arterial diameter by ϳ13 m, which reduced myogenic tone by ϳ51% (Fig. 4, C and D) . Collectively, these data indicate that SUR2B is expressed in both murine and human cerebral arteries and that pinacidil and hypoxia both induce vasodilation.
Vasodilation induced by OGD is attenuated in SUR2 mutant mouse cerebral arteries. To evaluate the physiological functions of SUR2-containing K ATP channels in OGD-induced cerebrovascular regulation, pressurized SUR2 wt and SUR2 nl mouse cerebral arteries were deprived of oxygen and glucose (OGD) for ϳ40 min, after which oxygen and glucose were restored. OGD dilated both SUR2 wt and SUR2 nl mouse cerebral arteries. In contrast to the vasodilatory response to hypoxia, OGD induced a biphasic vasodilation in both SUR2 wt and SUR2 nl arteries (Fig. 5A) . The time to half-maximal OGDinduced dilation was similar (P Ͼ 0.05) in SUR2 wt (7.3 Ϯ 0.9 min, n ϭ 5) and SUR2 nl (6.9 Ϯ 1.1 min, n ϭ 5) arteries. In was ϳ39% smaller in SUR2 nl than SUR2 wt arteries (Fig. 5, A  and B) .
Restoration of oxygen and glucose after 40 min of OGD resulted in only a partial recovery of myogenic tone in both SUR and SUR2 nl cerebral arteries (Fig. 5, A and C) . OGD increased mean arterial diameter by ϳ34 m in SUR2 wt arteries, and following restoration of normoxia and glucose, the arteries exhibited a chronic vasodilation of ϳ16 m. In SUR2 nl arteries, OGD induced a dilation of ϳ21 m, and following the reestablishment of oxygen and glucose, there was a sustained vasodilation of ϳ5 m. Thus, following the restoration of oxygen and glucose, SUR nl arteries regained ϳ69% more tone than did SUR wt arteries (Fig. 5, A and C) . The partial recovery of tone and the difference in recovery between SUR2 wt and SUR2 nl lasted for as long as the measurements were made (up to 60 min), indicating that the loss of tone was not an acute response but sustained. These data indicate that 1) SUR2-containing K ATP channels contribute to OGD-induced vasodilation and 2) activation of SUR2-containing K ATP channels is involved in the postischemic loss of myogenic tone.
SUR2B contributes to vasodilation induced by mitochondrial inhibition.
We investigated the hypothesis that mitochondrial metabolism controls arterial contractility through SUR2B. To test this hypothesis, the diameter regulation by oligomycin B, a mitochondrial ATP synthase blocker, and carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler, was studied in pressurized (60 mmHg) SUR2 wt and SUR2 nl mouse cerebral arteries (28) . Oligomycin B and CCCP increased the mean diameter of SUR2 wt mouse cerebral arteries by ϳ20 and 28 m, respectively. In contrast, oligomycin B and CCCP dilated SUR2 nl arteries by only ϳ8 and 11 m, respectively, responses that were ϳ60 and 61% smaller than in SUR2 wt arteries, respectively (Fig. 6A) .
Washout of oligomycin B and CCCP from SUR2 wt and SUR2 nl mouse cerebral arteries resulted in a partial loss of myogenic tone (Fig. 6B ) that was similar to the response observed post-OGD (Fig. 5, A-C) . In SUR2 wt arteries, oligomycin B and CCCP washout resulted in a sustained steadystate vasodilation of ϳ15 and 11 m, respectively. In contrast, in SUR2 nl arteries the sustained vasodilation following oligomycin B and CCCP washout was ϳ6 and 2 m, respectively. Thus, after oligomycin B or CCCP removal, SUR2 nl arteries recovered ϳ60 and 82% more myogenic tone, respectively, than did SUR2 wt cerebral arteries (Fig. 6B) . These findings indicate that mitochondrial inhibition dilates cerebral arteries by activating SUR2-containing K ATP channels. The data also indicate that mitochondrial inhibition induces a persistent loss of myogenic tone because of the activation of SUR2-containing K ATP channels.
DISCUSSION
Here we investigated the physiological functions of SUR2-containing K ATP channels in hypoxia-and OGD-induced cerebral artery vasodilation. Our data demonstrate that mouse cerebral artery myocytes express only the SUR2B K ATP channel subunit. We also show that small human cerebral arteries express SUR2B, develop spontaneous myogenic tone, and dilate in response to hypoxia and pinacidil. Cerebral arteries from SUR2 wt and SUR2 nl mice develop similar levels of myogenic tone and dilate similarly to hypoxia. In contrast, pinacidil, OGD, and mitochondrial inhibition all induce smaller vasodilation in SUR2 nl cerebral arteries. SUR2 abolishment also attenuates a loss in myogenic tone that occurs after the restoration of oxygen and glucose or mitochondrial inhibition. Collectively, the data indicate that SUR2-containing K ATP channels contribute to vasodilation induced by OGD and mitochondrial inhibition but do not contribute to hypoxic vasodilation. The data also indicate that SUR2 contributes to a loss of myogenic tone after recovery from OGD or mitochondrial inhibition.
The contribution of K ATP channels to hypoxic vasodilation remains controversial. Previous studies that investigated the importance of K ATP channels used glibenclamide as a K ATP channel inhibitor. Glibenclamide attenuated hypoxic vasodilation in rat and rabbit pial arterioles in vivo, coronary arteries in isolated perfused guinea pig hearts, and pressurized rat middle cerebral arteries with intraluminal perfusion (8, 19, 20, 35, 39) . In contrast, glibenclamide did not alter hypoxic vasodilation of rat femoral artery rings, pressurized rat coronary arteries, or piglet cerebral arteries in vivo (18, 22, 33) . Collectively, these studies suggest that the physiological functions of K ATP channels in mediating hypoxic vasodilation may depend on age, species, anatomical origin of arteries, or experimental methods employed, including the use of pharmacological tools. Glibenclamide inhibits both plasma membrane and mitoK ATP channels and exhibits nonselective effects that include inhibition of Na ϩ -K ϩ ATPase and inducible nitric oxide synthase (34, 41, 43) . In another study, glibenclamide did not alter pinacidilinduced relaxation of rat anterior cerebellar arteries (24) . Based on this conflicting evidence, for the first time we used a genetic model to investigate the physiological functions of SUR2-containing K ATP channels in mediating vasodilation to hypoxia, OGD, and metabolic inhibition. We found that SUR2B is the only SUR isoform expressed in resistance-size cerebral artery myocytes, consistent with our previous findings in mesenteric artery myocytes (1) . A previous study demonstrated that SUR2B is expressed in human brain and intracranial arteries, which contain multiple cell types in addition to myocytes (31) . We also show that human cerebral arteries express SUR2B and dilate to pinacidil and hypoxia. We have previously shown that the genetic ablation of SUR2 abolishes vascular myocyte K ATP currents and attenuates pinacidil-induced dilation of pressurized mesenteric arteries (1, 16) . Consistent with these studies, pinacidil-induced vasodilation was markedly attenuated in cerebral arteries from SUR2 nl mice. Our findings here indicate that SUR2-containing K ATP channels do not contribute to hypoxic vasodilation in cerebral arteries. Pinacidil-induced dilation was not abolished in SUR2 nl arteries, consistent with our previous studies in mesenteric arteries (1). The mechanism for SUR2-independent pinacidil-induced vasodilation is unclear but may involve a stimulation of plasma membrane Ca 2ϩ extrusion and a reduction in contractile protein Ca 2ϩ sensitivity (25) . In contrast to effects of hypoxia, OGD-induced vasodilation was attenuated in SUR2 nl arteries. OGD-induced vasodilation was not abolished in SUR2 nl arteries, indicating that SUR2-independent targets also contribute to this response. SUR2-independent OGD-induced mechanisms are unclear but may include free radicals, lactate, nitric oxide, and prostaglandins (46) . Oligomycin B-and CCCP-induced vasodilation were also attenuated in SUR nl arteries, suggesting that mitochondrial inhibition, and specifically mitochondrial ATP synthase block, activates SUR2-containing K ATP channels to induce vasodilation. A major regulator of K ATP channel activity is the intracellular ATP-to-ADP ratio (ATP/ADP), with a fall in this ratio leading to K ATP channel activation (2) . Relative changes in ATP/ADP may explain why hypoxia, which would presumably cause a smaller decrease in ATP/ADP, does not activate SUR2-containing K ATP channels, whereas OGD and mitochondrial inhibitions, which would induce a larger reduction in ATP/ADP, do activate SUR2-containing K ATP channels. Indeed, the levels of hypoxia that induce vasodilation cause insignificant changes in arterial intracellular ATP concentration (13, 30) , which may explain the lack of contribution of SUR2-containing K ATP channels to hypoxic vasodilation. OGD will cause a combined inhibition of glycolysis and oxidative phosphorylation, which should cause a greater reduction in arterial myocyte ATP, leading to K ATP channel activation. Previous studies indicate that OGD reduced intracellular ATP by 70 -92% in hippocampus slices (11, 14) . It is important to also consider the potential involvement of mitoK ATP channels in mediating vasodilation to pinacidil, hypoxia, and OGD. Pinacidil, a mitoK ATP channel activator, induces weak mitochondrial depolarization in cerebral artery smooth muscle cells and dilates via cerebral artery plasma membrane K ATP channel activation (44) . Vasodilation to diazoxide, another mitoK ATP channel activator, is similar in arteries from SUR2 wt and SUR2 nl mice and can be explained by electron transport chain II inhibition (1) . Although the molecular composition of arterial smooth muscle cell mitoK ATP channels is unclear, this recent evidence suggests that mitoK ATP channels in cerebral artery smooth muscle cells may not contain full-length SUR subunits (1, 44) . Here our data suggest that hypoxic vasodilation does not involve a SUR-containing plasmalemmal or mitoK ATP channel. The involvement of SUR2B-containing mitoK ATP channels in OGD-induced vasodilation is unclear, but evidence suggests this is unlikely. In summary, our data indicate that OGD dilates cerebral arteries by activating SUR2-containing plasmalemmal K ATP channels, and although the mechanism is unclear, it likely involves a fall in intracellular ATP/ADP.
Cerebral artery autoregulation maintains vascular tone and contributes to the reestablishment of blood flow (reperfusion) following cerebral ischemia (17) . Successful reperfusion can alleviate brain injury by restoring delivery of oxygen, glucose, and nutrients (17) . Postischemic hyperemia at reperfusion can also induce cerebral edema, thereby aggravating brain injury (17) . Reperfusion alters vascular tone and increases arterial wall thickness and stiffness (6, 7) . However, mechanisms that underlie postischemic alterations in cerebrovascular reactivity are poorly understood. Here, following restoration of oxygen and glucose and after washout of mitochondrial inhibitors, the arteries did not return the arteries to their steady-state control diameter. This loss of myogenic tone was markedly attenuated in SUR2 nl mouse cerebral arteries. Of note is that pinacidil induced far larger vasodilation in SUR2 wt than SUR2 nl arteries, but myogenic tone following pinacidil washout was similar in both SUR and SUR2 nl arteries. Therefore, the loss of myogenic tone following OGD, oligomycin B, or CCCP is not due to the degree of vasodilation caused by these manipulations. Similar data were obtained with OGD, CCCP, and oligomycin B, and the loss of myogenic tone was maintained up to 60 min after oxygen/glucose restoration or CCCP/oligomycin B washout. Therefore, these responses are unlikely to be due to poor washout of CCCP or oligomycin B, particularly since differences occurred between SUR2 wt and SUR2 nl arteries. One interpretation of these data is that OGD, oligomycin B, and CCCP cause dysfunction that inhibits mitochondria from restoring cellular ATP/ADP to control levels, resulting in persistent plasma membrane K ATP channel activation and vasodilation. Although the mechanisms by which SUR2 mediates this effect will require future study, our findings suggest that the loss of SUR2 maintains postischemic myogenic tone, which would protect against cerebrovascular dysregulation.
Genetic ablation of Kir6.2 subunits elevates ischemia-reperfusion injury in the heart (38) . In contrast, SUR1 knockout mice and SUR2 nl mice are protected against acute cardiovascular stress and ischemia-reperfusion cardiac injury (10, 37) . These studies suggest that Kir6.2 and SUR proteins differentially regulate myocardial injury following ischemia. Our findings are consistent with those in heart, indicating that SUR2 loss protects cerebral arteries following ischemia-reperfusion by preserving the myogenic response. These data are relevant when designing future therapies to preserve vascular function following ischemia, including that preceding and following stroke. For example, K ATP channel inhibition, specifically Fig. 6 . Vasodilation induced by mitochondrial inhibition and loss of myogenic tone following washout are attenuated in SUR2nl cerebral arteries. A: mean data illustrating that oligomycin B (1 M; SUR2wt, n ϭ 6 for each; and SUR2nl, n ϭ 8 for each)-and CCCP (1 M; SUR2wt, n ϭ 4 for each; and SUR2nl, n ϭ 5 for each)-induced vasodilation is smaller in SUR2nl than in SUR2wt arteries. B: mean data demonstrating that the sustained vasodilation after washout of oligomycin B (SUR2wt, n ϭ 6 for each; and SUR2nl, n ϭ 8 for each) or CCCP (SUR2wt, n ϭ 4 for each; and SUR2nl, n ϭ 5 for each) is smaller in SUR2nl than in SUR2wt mouse cerebral arteries. *P Ͻ 0.05 compared with SUR2wt. SUR2B targeting, would be expected to attenuate vasodilation during ischemia but improve vascular function following reperfusion. Available K ATP channel blockers, including glibenclamide, may be useful, but their efficacy will require additional study since these blockers typically bind multiple SUR isoforms, impact a wide variety of cell types, and have non-K ATP channel effects. Future studies should be designed to determine the benefits of targeting SURs on cerebrovascular function during and following ischemia.
Murine cardiac myocytes express both full-length (130 kDa) and short (28, 55 , and 68 kDa) SUR2 forms (32, 45) . Fulllength SUR2 is absent, whereas all three short forms are present, in SUR2 nl mouse cardiac myocytes (32) . Whether wild-type and SUR2 nl mouse cerebral artery myocytes express SUR2 short forms is unclear. Also, unknown is the contribution of SUR2 short forms to hypoxia and OGD vasodilation. Future studies should aim to determine arterial myocyte SUR2 short-form expression and vasoregulation by short SUR2s.
In conclusion, we demonstrate that SUR2-containing K ATP channels are functionally significant for OGD, but not hypoxic, vasodilation in cerebral arteries. Our data also indicate that SUR2 nl arteries are protected from OGD-induced loss of myogenic tone, suggesting that a SUR2-mediated mechanism contributes to postischemic myogenic tone loss and that SUR2 targeting may be a viable therapy to improve vascular function following ischemia.
